BMS Consolidates U.S., International Pharmaceutical Operations

Drug Industry Daily
KEYWORDS Deals
A A

Bristol-Myers Squibb (BMS) is combining its U.S. and international pharmaceutical operations — one of several organizational shake-ups announced Sept. 20 by the New York-based firm.

To View This Article:

Login

Subscribe To Drug Industry Daily